Month: June 2024

SHANGHAI, June 03, 2024 (GLOBE NEWSWIRE) — GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China and South East Asia, today announced that it will hold its 2024 Annual General Meeting of Shareholders (the “AGM”) at Garden Suite, Mandarin Oriental, Singapore, 5 Raffles Avenue, Singapore at 4:00 p.m. (China Standard Time) on June 27, 2024 (which is 4:00 a.m. (Eastern Daylight Time) on June 27, 2024). Holders of the Company’s ordinary shares and Series A convertible preferred shares listed in the register of members of the Company at the close of business on June 5, 2024 (China Standard Time) are entitled to receive notice of, and vote at, the AGM or at any adjournment that may take place. Beneficial owners of the Company’s...

MISSISSAUGA, Ontario, June 03, 2024 (GLOBE NEWSWIRE) — KP Tissue Inc. (“KPT” or the “Company”) (TSX:KPT) would like to remind shareholders to vote in connection with the Company’s upcoming annual meeting of shareholders (the “Meeting”), to be held on Tuesday, June 11, 2024 at 2:00 PM ET. Shareholders are advised to vote their shares well in advance of the proxy voting deadline of Friday, June 7, 2024 at 2:00 PM ET. YOUR VOTE IS IMPORTANT NO MATTER HOW MANY SHARES YOU HOLD.PLEASE VOTE YOUR SHARES TODAY. THE BOARD OF DIRECTORS RECOMMENDS THAT SHAREHOLDERS VOTE FOR ALL MEETING RESOLUTIONS. Shareholders are encouraged to read the materials relating to the Meeting, available on the Company’s website www.kptissueinc.com as well as under KPT’s profile at www.sedarplus.ca. In the interest of time, shareholders may vote online or by telephone...

MIDVALE, Utah, June 03, 2024 (GLOBE NEWSWIRE) — Beyond, Inc. (NYSE:BYON), owner of Overstock, Bed Bath & Beyond, Zulily, and other online retail brands designed to unlock your home’s potential, today announced that the company will be participating in the following investor events:UBS Consumer Insights Day, with virtual participation and a fireside chat on June 13, 2024 at 11:30 a.m. ET. This fireside chat will be webcast to UBS clients only.Jefferies Consumer Conference in Nantucket on June 17-18, 2024. This conference is not being webcast.About Beyond Beyond, Inc. (NYSE:BYON), based in Midvale, Utah, is an ecommerce expert with a singular focus: connecting consumers with products and services that unlock their homes’ potential. The Company owns Overstock, Bed Bath & Beyond, Baby & Beyond, Zulily, and other...

Jan Schellens, M.D., Ph.D., as Chief Medical Officer (CMO)Lixte Biotechnology Holdings, Inc.PASADENA, Calif., June 03, 2024 (GLOBE NEWSWIRE) — LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical-stage pharmaceutical company developing a new class of cancer therapy to enhance chemotherapy and immunotherapy, today announced the appointment of Jan Schellens, M.D., Ph.D., as Chief Medical Officer (CMO). Dr. Schellens brings to LIXTE more than 25 years of clinical experience as a medical oncologist, pharmacologist and clinical pharmacologist, including more than two decades developing and bringing new drugs to market. He assumes the CMO role at LIXTE effective August 1, 2024, succeeding James S. Miser, M.D., who is leaving the Company after serving in this capacity since 2020. “Dr....

ROCKAWAY, N.J., June 03, 2024 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a commercial-stage bioelectronic medicine and wellness company, today announced that it has agreed to issue and sell to an institutional accredited investor an aggregate of 225,000 registered pre-funded warrants to purchase shares of common stock and unregistered warrants to purchase up to an aggregate of 112,500 shares of common stock. The pre-funded warrants were sold at a purchase price of $6.43 minus $0.001 per pre-funded warrant, and are exercisable immediately at an exercise price of $0.001 per share. Each share of common stock is being sold together with one-half of one warrant at a combined effective offering price of $6.4925 per share and related warrant. The warrants will be immediately exercisable after...

The integrated aPROMISE solution to be demonstrated on Siemens Healthineers’ syngo.via platform at the SNMMI annual meeting BEDFORD, Mass., June 03, 2024 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced that aPROMISE, its AI-enabled FDA-cleared medical device software, is now available on the syngo.via platform, from Siemens Healthineers, one of the leading workstation systems. Siemens Healthineers will be demonstrating the integrated solution at the upcoming annual Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting in Toronto June 8-11, 2024. aPROMISE is a deep learning-enabled, FDA-cleared medical device software that...

Clinical studies in anxiety and insomnia expected to commence in the third quarter of 2024 HOUSTON, TX, June 03, 2024 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) announces that the U.S. Food and Drug Administration (FDA) has provided feedback and reached consensus on the design for its planned clinical studies in anxiety and insomnia for its new Gen-3 HALO Clarity™ (“HALO”), a non-invasive, Deep Intracranial Frequency Stimulation (DIFS™) headset device designed to address the global mental health epidemic. After the studies are completed and evaluated, Nexalin plans to submit a De Novo request application for the HALO to the FDA. The De Novo request provides a marketing pathway to classify new novel medical devices. The initial pilot and pivotal studies for anxiety...

Innovative Formula To Be Available in Portable Format for Enhanced Accessibility and Convenience JUPITER, FL, June 03, 2024 (GLOBE NEWSWIRE) — Safety Shot, Inc. (Nasdaq: SHOT) (the “Company), announced today the launch of its revolutionary formula in new, convenient 4-ounce bottles. Designed for easy on-the-go use, this new format ensures that customers can enjoy the benefits of Safety Shot’s groundbreaking formula anytime, anywhere. Safety Shot is a first of its kind functional beverage crafted with Essential B vitamins, antioxidants, electrolytes, and nootropics designed to boost mental clarity, energy and overall mood. Disrupting the industry and creating a category of one, Safety Shot is the world’s first beverage to reduce blood alcohol content by supporting its metabolism in as little as 30 minutes. The 4-ounce bottles...